Advances in cardiac tissue engineering and heart‐on‐a‐chip
Journal of Biomedical Materials Research Part A · 2024
DOI: 10.1002/jbm.a.37633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Jennifer Kieda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Tissue Engineering, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, Canada Foundation for Innovation.
Abstract (Originalsprache)
Recent advances in both cardiac tissue engineering and hearts‐on‐a‐chip are grounded in new biomaterial development as well as the employment of innovative fabrication techniques that enable precise control of the mechanical, electrical, and structural properties of the cardiac tissues being modelled. The elongated structure of cardiomyocytes requires tuning of substrate properties and application of biophysical stimuli to drive its mature phenotype. Landmark advances have already been achieved with induced pluripotent stem cell‐derived cardiac patches that advanced to human testing. Heart‐on‐a‐chip platforms are now commonly used by a number of pharmaceutical and biotechnology companies. Here, we provide an overview of cardiac physiology in order to better define the requirements for functional tissue recapitulation. We then discuss the biomaterials most commonly used in both cardiac tissue engineering and heart‐on‐a‐chip, followed by the discussion of recent representative studies in both fields. We outline significant challenges common to both fields, specifically: scalable tissue fabrication and platform standardization, improving cellular fidelity through effective tissue vascularization, achieving adult tissue maturation, and ultimately developing cryopreservation protocols so that the tissues are available off the shelf.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
- Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Jennifer Kieda, Amid Shakeri, Yimu Zhao, Sargol Okhovatian, Ying Wang, Milica Radisic
Förderung
- NHLBI NIH HHS
- NIH HHS
- Canada Foundation for Innovation
- Canadian Institutes of Health Research
- National Institutes of Health
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Kieda, J., Shakeri, A., Landau, S., Wang, E. Y., Zhao, Y., Lai, B. F., Okhovatian, S., Wang, Y., Jiang, R., & Radisic, M. (2024). Advances in cardiac tissue engineering and heart‐on‐a‐chip. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37633
Vancouver
Kieda J, Shakeri A, Landau S, Wang EY, Zhao Y, Lai BF, et al. Advances in cardiac tissue engineering and heart‐on‐a‐chip. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37633
BibTeX
@article{Kieda2024,
author = {Kieda, Jennifer and Shakeri, Amid and Landau, Shira and Wang, Erika Yan and Zhao, Yimu and Lai, Benjamin Fook and Okhovatian, Sargol and Wang, Ying and Jiang, Richard and Radisic, Milica},
title = {Advances in cardiac tissue engineering and heart‐on‐a‐chip},
journal = {Journal of Biomedical Materials Research Part A},
year = {2024},
doi = {10.1002/jbm.a.37633}
}
EUVIMED